The study drug is exploring a potential new treatment for conditions with the digestive tract
Inflammatory diseases like Ulcerative Colitis and Crohn's Disease cause the immune system to attack itself, leading to inflammation and tissue damage. Current treatments may not fully address the underlying biological processes contributing to these symptoms.
We are evaluating the safety, tolerability, and effectiveness of a potential new treatment for Inflammatory Bowel Diseases, in healthy volunteers. This initial phase is crucial before testing the study medication in patients with these conditions. By participating, you will contribute to research that could enhance future treatments and positively impact individuals and families affected by these diseases.
Call us on 1300 523 969 to discuss your eligibility today!